Testing effectiveness (Phase 2)Study completedNCT02265809
What this trial is testing
Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes
Who this might be right for
Type 1 Diabetes
Cambridge University Hospitals NHS Foundation Trust 41